TissueTech raises $10M for regenerative medicine businesses

08/23/2013 | MassDevice.com (Boston)

TissueTech has secured $10 million in financing from River Cities Capital Funds and Ballast Point Ventures. The Doral, Fla.-based company will use the money to support research and development as well as fund the commercialization of regenerative medicine products developed by its Amniox Medical and Bio-Tissue units.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC